Clinical Trials Sponsored by Beta Pharma Shanghai

Total 58 results

Beta Pharma Shanghai

Active, not recruiting

A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients

NSCLC

China
Beta Pharma Shanghai

Completed

A Phase IIb Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients With T790M Mutation Positive

NSCLC

China
Beta Pharma Shanghai

Completed

BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Beta Pharma, Inc.

Completed

A Phase I Study to Assess the Effect of Itraconazole and Rifampicin on Pharmacokinetics Profile of BPI-7711

NSCLC

China
Beta Pharma, Inc.

Completed

A Phase I Study to Determine the Effect of Food on the Pharmacokinetic Profile of BPI-7711

NSCLC

China
Beta Pharma (Suzhou) Co., Ltd.

Recruiting

A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer

Advanced Solid Tumor | HR+/HER2- Breast Cancer

China
Shanghai Kechow Pharma, Inc.

Recruiting

A PhaseI Study of HL-085 Plus Vemurafenib in Solid Tumor With BRAF V600 Mutation

Solid Tumor

China
Shanghai Kechow Pharma, Inc.

Terminated

Study of HL-085 Plus Docetaxel in Patients With KRAS Mutant NSCLC

Nsclc

China
Shanghai Kechow Pharma, Inc.

Not yet recruiting

Efficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical Study

Non-small-cell Lung Cancer
Shanghai Kechow Pharma, Inc.

Recruiting

HL-085+Vemurafenib to Treat Advanced Melanoma Patients With BRAF V600E/K Mutation

Melanoma

China
Shanghai Kechow Pharma, Inc.

Completed

Study of HL-085 in NRAS Mutant Advanced Melanoma

Melanoma

China
Shanghai Kechow Pharma, Inc.

Completed

HL-085 in NRAS-mutated Advanced Melanoma

Melanoma

China
Shanghai Kechow Pharma, Inc.

Not yet recruiting

Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer

Colorectal Cancer Metastatic
Shanghai Kechow Pharma, Inc.

Not yet recruiting

Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma

Melanoma

China
Shanghai Kechow Pharma, Inc.

Recruiting

HL-085 in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas

Neurofibromatosis 1 | Plexiform Neurofibromas

China
Shanghai Kechow Pharma, Inc.

Recruiting

Study of HL-085 and Vemurafinib in Metastatic Colorectal Cancer (mCRC) (mCRC)

CRC

China
Shanghai Kechow Pharma, Inc.

Terminated

Phase I Study of HL-085 in Patients With Advanced Solid Tumors

Solid Tumor, Adult

United States
Kechow Pharma, Inc.

Completed

Study of HL-085 in Patients With Advanced Solid Tumor Tumors

Solid Tumor, Adult

United States
Nuance Pharma (shanghai) Co., Ltd

Completed

Evaluate the Pharmacokinetics and Safety of EXPAREL® Following Subcutaneous Administration in Healthy Chinese Subjects

Healthy Subjects

China
Shanghai Pharma Biotherapeutics USA Inc.

Recruiting

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

Liposarcoma, Dedifferentiated

United States
Shanghai Pharma Biotherapeutics USA Inc.

Recruiting

Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis

Ulcerative Colitis

United States
Nuance Pharma (shanghai) Co., Ltd

Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Nebulized Ensifentrine in Healthy Chinese Subjects

Chronic Obstructive Pulmonary Disease

China
Nuance Pharma (shanghai) Co., Ltd

Completed

A Pharmacokinetic Study of Intravenous NTM-001 in Healthy Chinese Subjects

Healthy Volunteers

China
Zealand Pharma
Massachusetts General Hospital; Beta Bionics, Inc.

Completed

Feasibility Trial Testing the Bionic Pancreas With ZP4207 (dasiglucagon)

Diabetes Mellitus, Type 1

United States
Massachusetts General Hospital
Zealand Pharma; Beta Bionics, Inc.

Completed

The Bihormonal iLet Bionic Pancreas Feasibility Study

Type 1 Diabetes Mellitus

United States
Taizhou EOC Pharma Co., Ltd.
Shanghai Zhongshan Hospital; Shanghai East Hospital

Unknown

Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer

Gastric Cancer

China
UCB Pharma
UCB Trading (Shanghai) Co. Ltd.

Completed

Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients

Idiopathic Parkinson's Disease

China
Zhejiang University
Beta Pharma, Inc.; Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

Lung Cancer

China
Newark Beth Israel Medical Center
Astellas Pharma Inc

Completed

Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients (TICTAC)

Immunosuppression

United States
CARE Pharma Shanghai Ltd.

Recruiting

A Study on the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of CAN106 in Subjects With PNH

Hemolysis | PNH

China
CARE Pharma Shanghai Ltd.

Completed

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Single Ascending Dose (SAD) of CAN106 Administered Intravenously (IV) in Healthy Subjects

PNH

Singapore
CARE Pharma Shanghai Ltd.

Completed

Natural History Study of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria of High-risk Hemolysis in China

Paroxysmal Nocturnal Hemoglobinuria, Natural History Study

China
Genuine Research Center, Egypt
Zeta Pharma Pharmaceutical Industries

Completed

Bioequivalence Study of Daclatasvir From Daclatasvir Zeta 60 mg Film Coated Tablets (Zeta Pharm Pharmaceutical Industries, Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

Healthy

Egypt
Sumitomo Pharma (Suzhou) Co., Ltd.
Xuhui Central Hospital, Shanghai

Completed

Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects

Schizophrenia

China
Nuance Pharma (shanghai) Co., Ltd
Laboratory Corporation of America

Recruiting

A Study to Evaluate the Efficacy and Safety of Ensifentrine for 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

China
Shanghai YingLi Pharmaceutical Co. Ltd.
Yingli Pharma US, Inc

Recruiting

YL-13027 in Patients With Advanced Solid Tumors

Solid Tumor

United States
Shanghai YingLi Pharmaceutical Co. Ltd.
Yingli Pharma US, Inc

Recruiting

A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation

Advanced Solid Tumor

United States
Visen Pharmaceuticals (Shanghai) Co., Ltd.
Ascendis Pharma A/S

Unknown

Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency

Endocrine System Diseases | Pituitary Diseases | Growth Hormone Deficiency | Hormones | Pituitary Disease, Anterior

China
Sumitomo Pharma (Suzhou) Co., Ltd.
Xuhui Central Hospital, Shanghai

Completed

A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects

Schizophrenia

China
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Oyster Point Pharma, Inc.

Completed

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease

Dry Eye Disease

China
Sunshine Lake Pharma Co., Ltd.
Nicoya Therapeutics (Shanghai) Co., Ltd.

Not yet recruiting

HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia

Chronic Kidney Diseases | Renal Anemia

China
Sunshine Lake Pharma Co., Ltd.
Nicoya Therapeutics (Shanghai) Co., Ltd.

Not yet recruiting

Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis.

Hemodialysis | Peritoneal Dialysis

China
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Oyster Point Pharma, Inc.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease

Dry Eye Disease

China
Solasia Pharma K.K.
Solasia Medical Information Consulting (Shanghai) Co. Ltd.

Completed

A Trial of Episil® Oral Liquid in Cancer Patients Suffering From Chemotherapy- and/or Radiation-induced Oral Mucositis

Chemotherapy- and/or Radiation-induced Oral Mucositis

China
Shanghai Pharmaceuticals Holding Co., Ltd
R&G Pharma Studies Co.,Ltd.

Completed

Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

Hypertension,Essential

China
Shanghai Changzheng Hospital
JiangSu Chia-Tai Tianqin Pharmacy Co.Ltd

Completed

Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomiting (ESPNV)

Neoplasms | Chemotherapy-Induced Nausea and Vomiting

China
Shanghai Jiao Tong University Affiliated Sixth...
Chugai Pharma China Co., Ltd.

Not yet recruiting

Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis (EFFECT)

Postmenopausal Osteoporosis | Low Bone Mineral Density

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Shanghai Public Health Clinical Center; Beijing Simoonrecord Pharmaceutical...

Completed

A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)

Tuberculosis

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Shanghai Public Health Clinical Center; Air Force Military Medical University... and other collaborators

Completed

Phase I Clinical Human Tolerability Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10

Healthy
Kexing Biopharm Co., Ltd.
The Third Hospital of Changsha; Guoxin Pharmaceutical Technology (Beijing)... and other collaborators

Active, not recruiting

A Phase I Study of Human Interferon Alfa 1b Inhalation Solution in Healthy Participants

Healthy Participants

China

Clinical Trials Sponsored by Beta Pharma Shanghai

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations